Videos

Mati Therapeutics

By Jackie Wengrod | November 23, 2015

Mati is developing a punctal plug drug delivery technology for sustained drug delivery using an “L-shaped” design to deliver medications to the canalicular space. Insertion…

Read More

Graybug

By Jackie Wengrod | November 23, 2015

Graybug is developing injectable controlled-release technologies to allow dosing once every four to six months for the treatment of neovascular age-related macular degeneration (AMD), thereby…

Read More

AcuFocus

By Jackie Wengrod | November 23, 2015

AcuFocus is committed “to continuously adapting and expanding” its small aperture technology. The company’s first device, the KAMRA, received US regulatory approval in April 2015,…

Read More

ReVision Optics

By Jackie Wengrod | November 23, 2015

The presbyopia market is estimated to comprise more than 2 billion people by 2020. ReVision Optics has developed the Raindrop Near Vision inlay to address…

Read More

Avedro

By Jackie Wengrod | November 23, 2015

Avedro has submitted its New Drug Application for its riboflavin ophthalmic solution/KXL System (corneal cross-linking for the treatment of keratoconus and corneal ectasia following refractive…

Read More

ClarVista Medical

By Jackie Wengrod | November 23, 2015

ClarVista is a privately held, clinical- and commercial-stage ophthalmology device company concentrating solely on the development of the Harmoni modular intraocular lens (IOL) system. While…

Read More

Mynosys Cellular Devices

By Jackie Wengrod | November 23, 2015

Zepto is an innovative disposable device, used in cataract surgery that uses precision pulse technology. The company notes the device is accurate and creates a…

Read More

PowerVision

By Jackie Wengrod | November 23, 2015

PowerVision has developed “the first true shape-changing, fluid driven intraocular lens (IOL),” CEO Barry Cheskin said. The FluidVision IOL creates a “continuously variable monofocal” where…

Read More

RPS Diagnostics

By Jackie Wengrod | November 23, 2015

RPS is a diagnostic company concentrating on inflammatory and infectious disease diagnoses; its flagship product, the InflammaDry, has been designed for in-office diagnosis of inflammatory…

Read More

Saunders Speaks to Allergan’s Innovative Culture

By Jackie Wengrod | November 23, 2015

Prior to the announcement of the Pfizer-Allergan combination, Allergan CEO and President Brent Saunders spoke with OISTV about how the pharma industry finds and foster…

Read More

Brent Saunders, President & CEO of Allergan

By Jackie Wengrod | November 19, 2015

Brent Saunders delivers a data-packed presentation about the state of innovation in the life sciences industry and discusses where ophthalmology fits into Allergan’s future. Participant:…

Read More

Transcend Medical

By Jackie Wengrod | November 18, 2015

The year 2015 represented a milestone for Transcend Medical – it completed a milestone study and filed a Premarket Approval for a minimally invasive glaucoma…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.